Table 2 Characteristics of the 6 PD cases who carried UQCRC1 HC PTVs

From: Protein-truncating variants in UQCRC1 are associated with Parkinson’s disease: evidence from half-million people

Snp

Chr

Pos

Ref

Alt

AF

gnomAD AF

Variant type

Age at diagnosis

Source

Sex

AA

AApos

GQ

DP

rs369886828

3

48604321

G

A

2.13E−05

1.95E−05

Stop gained

70–75

HS

M

R/*

180

40

64

rs763576784

3

48600726

CACAG

C

2.98E−05

4.15E−05

Frameshift

75–80

HS

F

VC/X

359–360

41

87

rs763576784

3

48600726

CACAG

C

2.98E−05

4.15E−05

Frameshift

70–75

HS

F

VC/X

359–360

39

66

rs1185146623

3

48603588

G

A

4.26E−06

3.39E−06

Stop gained

75–80

HS

M

R/*

228

41

59

rs1406017546

3

48599659

G

A

2.13E−06

1.70E−06

Stop gained

65–70

HS

F

Q/*

452

39

75

rs2531432332

3

48600152

C

A

3.19E−06

3.39E−06

Splice acceptor

65–70

HS

F

33

43

  1. HC high confidence, AA amino acid, AApos amino acid position, Pos position, AF allele frequency for European (non-Finnish) in gnomAD 4.1.0., GQ genotype quality, DP depth of coverage, HS hospital secondary.